Sjogren's syndrome Clinical Trials
A listing of Sjogren's syndrome medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.
A randomized, double-blind, placebo controlled, 3-arm multicenter phase 3 study to assess the efficacy and safety of ianalumab in patients with active Sjögren’s syndrome
Participants who complete the 52-week treatment will be entitled to receive ianalumab treatment thereafter via Post Trial Access, in a separate extension study.
- 0 views
- 30 Dec, 2022
- 1 location